Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study. - Vigipallia

0 avis

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.

Archive ouverte

Marabelle, Aurelien | Le, Dung T. | Ascierto, Paolo A. | Di Giacomo, Anna Maria | de Jesus-Acosta, Ana | Delord, Jean-Pierre | Geva, Ravit | Gottfried, Maya | Penel, Nicolas | Hansen, Aaron R. | Piha-Paul, Sarina A. | Doi, Toshihiko | Gao, Bo | Chung, Hyun Cheol | Lopez-Martin, Jose | Bang, Yung-Jue | Frommer, Ronnie Shapira | Shah, Manisha | Ghori, Razi | Joe, Andrew K. | Pruitt, Scott K. | Diaz, Luis A.

Edité par CCSD ; American Society of Clinical Oncology -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies

Archive ouverte | Chung, Hyun Cheol | CCSD

International audience

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

Archive ouverte | Marabelle, Aurélien | CCSD

International audience

Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study

Archive ouverte | Marabelle, Aurelien | CCSD

International audience

Chargement des enrichissements...